公司資料
MiMedx 股價、新聞與催化劑
- 股票代碼:
- MDXG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.19 USD (-1.87%)
收盤價
最後更新: 2026年8月17日
532M USD
市值
股價為何變動
As of Aug 17, 2026, MDXG closed down 1.87% at $4.19. No new same-company headline was identified in the current news window.
公司概覽
Placental Tissue Products
MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair.
Wound-Care Portfolio
The company has more than a decade of experience serving chronic and difficult-to-heal wounds. Products are used by clinicians across outpatient and other care settings where advanced wound coverage and healing support are required.
Surgical and Pipeline Products
The surgical portfolio includes AMNIOFIX, AMNIOEFFECT and particulate products. MIMEDX is also investing in newer products such as CHORIOFIX and in a randomized controlled study of EPIEFFECT.
未來催化劑
- MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science. The company improves when the commercial base keeps compounding.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。